News
20 Years Growing Together
The Story of Kymos and PharmaMar: a journey of collaboration and succes Not many companies can celebrate 20 years of collaboration after reporting their best revenues ever and having become a successful multinational group, (...)
Pharmaprogress’ real-life cases in AEFI symposium Round Table on Nitrosamines
Pharmaprogress’ real-life cases in AEFI symposium Round Table on Nitrosamines Luca Gramaccioni, Site General Manger at Kymos Pharmaprogress, was a guest speaker at the 40th AEFI symposium last May 11th. He presented “Nitrosamines: How (...)
Your Stability Studies in Safe Hands
In recent years Kymos has experienced a surge in demand from drug manufacturers in need of a reliable outsourcing partner for their stability programmes. Kymos responded by making a major investment to build new (...)
The revolution in COVID vaccine development
The new COVID-19 vaccine developed by Pfizer/BioNTech was approved by the EMA last December and now Moderna’s is following suit. Both are based on mRNA technology and represent a very different type of vaccine (...)
